Last reviewed · How we verify
NCT04408105: SCREEN-BE
Survey Study on Barrett's Esophagus Screening
trial testing Primary Care Provider Survey in Gastroesophageal Reflux Disease in 725 participants. Completed in 1 October 2025.
23 September 2021
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 725 |
| Start date | 19 February 2020 |
| Primary completion | 23 September 2021 |
| Estimated completion | 1 October 2025 |
| Sites | 7 locations across United States |
Drugs / interventions tested
- Primary Care Provider Survey
- Gastroenterologist Survey
- Patient Survey
Conditions studied
- Gastroesophageal Reflux Disease — all drugs for Gastroesophageal Reflux Disease →
- Barrett's Esophagus — all drugs for Barrett's Esophagus →
- Esophagus Adenocarcinoma — all drugs for Esophagus Adenocarcinoma →
Sponsor
University of Colorado, Denver
Who can join
Adults 18 to 99, any sex, with Gastroesophageal Reflux Disease or Barrett's Esophagus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening.
Kolb JM, Chen M, Tavakkoli A, Gallegos J, et al · · 2023 · cited 16× · PMID 36219171 · DOI 10.14309/ajg.0000000000002054 -
Understanding Compliance, Practice Patterns, and Barriers Among Gastroenterologists and Primary Care Providers Is Crucial for Developing Strategies to Improve Screening for Barrett's Esophagus.
Kolb JM, Chen M, Tavakkoli A, Singal AG, et al · · 2022 · cited 13× · PMID 35150724 · DOI 10.1053/j.gastro.2022.02.003
Verify or expand the search:
- PubMed search for NCT04408105
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastroesophageal Reflux Disease
Currently open trials in the same condition.
- NCT06783751 — Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG) · NA · recruiting
- NCT06348420 — Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment · NA · recruiting
- NCT06991348 — Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Dise · Phase 4 · recruiting
- NCT06732661 — Preserving the Pre-cardial Fat Pad During Sleeve Gastrectomy on Postoperative Gastroesophageal Reflux · NA · active not recruiting
- NCT05514769 — Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer · NA · recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04408105 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 22 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04408105.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing